KLAY BIOTECH LIMITED

Get instant AI-powered insights about this company's financial health, risks, and trends.

Date	Description
03/12/243 December 2024	Confirmation statement made on 2024-12-03 with updates View Document
22/08/2422 August 2024	Total exemption full accounts made up to 2023-12-31 View Document
13/02/2413 February 2024	Registered office address changed from 35 Ballards Lane London N3 1XW United Kingdom to 73 Cornhill London EC3V 3QQ on 2024-02-13 View Document
31/12/2331 December 2023	Annual accounts for year ending 31 Dec 2023 View Accounts
06/12/236 December 2023	Confirmation statement made on 2023-12-03 with no updates View Document
08/11/238 November 2023	Termination of appointment of Jeremy Littman as a director on 2023-10-17 View Document
14/07/2314 July 2023	Total exemption full accounts made up to 2022-12-31 View Document
31/12/2231 December 2022	Annual accounts for year ending 31 Dec 2022 View Accounts
08/12/228 December 2022	Confirmation statement made on 2022-12-03 with updates View Document
25/11/2225 November 2022	Director's details changed for Mr Jeremy Littman on 2022-11-01 View Document
11/05/2211 May 2022	Resolutions View Document
11/05/2211 May 2022	Statement of capital following an allotment of shares on 2022-04-25 View Document
11/05/2211 May 2022	Change of share class name or designation View Document
11/05/2211 May 2022	Resolutions View Document

11/05/2211 May 2022	Resolutions View Document
11/05/2211 May 2022	Resolutions View Document
11/05/2211 May 2022	Memorandum and Articles of Association View Document
31/12/2131 December 2021	Annual accounts for year ending 31 Dec 2021 View Accounts
08/12/218 December 2021	Confirmation statement made on 2021-12-03 with updates View Document
18/01/2118 January 2021	DIRECTOR'S CHANGE OF PARTICULARS / MR NOOR UL OWASE JEELANI / 07/01/2021 View Document
18/01/2118 January 2021	DIRECTOR'S CHANGE OF PARTICULARS / MR DAVID JAMES DUNAWAY / 07/01/2021 View Document
11/01/2111 January 2021	DIRECTOR APPOINTED MR JEREMY LITTMAN View Document
11/01/2111 January 2021	DIRECTOR APPOINTED MR DAVID JAMES DUNAWAY View Document
11/01/2111 January 2021	DIRECTOR APPOINTED MR NOOR UL OWASE JEELANI View Document
11/01/2111 January 2021	NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL NOOR UL OWASE JEELANI View Document
11/01/2111 January 2021	NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL DAVID JAMES DUNAWAY View Document
11/01/2111 January 2021	CESSATION OF HECTOR MACLEOD AS A PSC View Document
11/01/2111 January 2021	06/01/21 STATEMENT OF CAPITAL GBP 100 View Document
04/12/204 December 2020	CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION View Document